Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corbus Pharmaceuticals Holdings (CRBP) Share-based Compensation (2016 - 2025)

Corbus Pharmaceuticals Holdings has reported Share-based Compensation over the past 9 years, most recently at $799000.0 for Q4 2023.

  • For Q4 2023, Share-based Compensation fell 37.05% year-over-year to $799000.0; the TTM value through Dec 2023 reached $3.5 million, down 39.34%, while the annual FY2024 figure was $6.1 million, 77.09% up from the prior year.
  • Share-based Compensation for Q4 2023 was $799000.0 at Corbus Pharmaceuticals Holdings, down from $821000.0 in the prior quarter.
  • Over five years, Share-based Compensation peaked at $3.6 million in Q3 2020 and troughed at $799000.0 in Q4 2023.
  • A 5-year average of $2.2 million and a median of $2.4 million in 2020 define the central range for Share-based Compensation.
  • Biggest five-year swings in Share-based Compensation: surged 63.88% in 2019 and later crashed 48.23% in 2022.
  • Year by year, Share-based Compensation stood at $3.1 million in 2019, then fell by 24.41% to $2.3 million in 2020, then fell by 23.4% to $1.8 million in 2021, then fell by 29.23% to $1.3 million in 2022, then tumbled by 37.05% to $799000.0 in 2023.
  • Business Quant data shows Share-based Compensation for CRBP at $799000.0 in Q4 2023, $821000.0 in Q3 2023, and $823000.0 in Q2 2023.